Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.

Cite this paper

@article{Frampton2013DevelopmentAV, title={Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing.}, author={Garrett M. Frampton and Alex M. Fichtenholtz and Geoff A. Otto and Kai Wang and Sean R. Downing and Jie He and Michael Schnall-Levin and Jared White and Eric M Sanford and Peter An and James Sun and Frank S. Juhn and Kristina W Brennan and Kiel Iwanik and Ashley Maillet and Jamie K Buell and Emily White and Mandy Zhao and Sohail Balasubramanian and Selmira Terzic and Tina Richards and Vera Banning and L{\'a}zaro Hern{\'a}ndez Garc{\'i}a and Kristen Mahoney and Zac Zwirko and Amy L Donahue and Himisha Beltran and Juan Miguel Mosquera and Mark A. Rubin and Snjezana Dogan and Cyrus V. Hedvat and Michael F. Berger and Lajos Pusztai and Matthias Lechner and Chris Boshoff and M. E. Jarosz and Christine M Vietz and Alex N. Parker and V. A. Miller and Jeffrey S Ross and John A. Curran and Maureen T. Cronin and P. Stephens and Doron Lipson and R. Yelensky}, journal={Nature biotechnology}, year={2013}, volume={31 11}, pages={1023-31} }